CIK 0001951222 · Non-accelerated filer<br>Emerging growth company
SEALSQ Corp
Sign in to watch- Ticker
- LAES
- Exchange
- Nasdaq
- Industry
- Semiconductors & Related Devices
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- other
- Phone
- 212-336-2039
- Business address
- AVENUE LOUIS-CASAI 58, COINTRIN, Switzerland, 1216
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $170,294
- in 3 filings, $170K under 10b5-1 plans
Net −$170,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-08 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −15,000 | $2.20 | $33K | 0 |
| 2026-04-08 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.20 | $22K | 225,595 |
| 2026-04-07 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.14 | $21K | 235,595 |
| 2026-04-07 | Feuardent Moreira Andreas Chief Innovation Officer | Option exercise 10b5-1 | +10,000 | $0.01 | $100 | 10,000 |
| 2026-04-07 | Feuardent Moreira Andreas Chief Innovation Officer | Sale 10b5-1 | −10,000 | $2.31 | $23K | 0 |
| 2026-04-07 | Feuardent Moreira Andreas Chief Innovation Officer | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2026-04-06 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-04-06 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 15,000 | ||
| 2026-04-06 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.42 | $24K | 245,595 |
| 2026-04-02 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.45 | $25K | 255,595 |
| 2026-03-31 | Buonanno Franck Jean Vice-President, Global Sales | Sale 10b5-1 | −10,000 | $2.35 | $24K | 10,000 |
| 2026-03-30 | O'Hara John Charles Chief Financial Officer | Option exercise 10b5-1 | +100,000 | $0.01 | $1K | 265,595 |
| 2026-03-30 | O'Hara John Charles Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,000 | 100,000 | ||
| 2026-03-30 | O'Hara John Charles Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | +100,000 | 0 | ||
| 2026-03-27 | Buonanno Franck Jean Vice-President, Global Sales | Option exercise | +15,000 | $0.01 | $150 | 20,000 |
| 2026-03-27 | Buonanno Franck Jean Vice-President, Global Sales | Option exercise · Employee Stock Option (right to buy) | −15,000 | 20,000 | ||
| 2026-03-25 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.92 | $29K | 165,183 |
| 2026-03-24 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.90 | $29K | 175,183 |
| 2026-03-23 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.99 | $30K | 185,183 |
| 2026-03-20 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $3.00 | $30K | 195,183 |
Page 4 of 5 · 82 trades